Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
162.92
-1.64 (-1.00%)
Streaming Delayed Price
Updated: 12:40 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
March 18, 2024
Via
Benzinga
2 Top Dividend Stocks to Buy Hand Over Fist
March 17, 2024
Every company faces headwinds eventually. The top ones know how to bounce back.
Via
The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
March 14, 2024
Via
Benzinga
How Much a $1 Million Portfolio Would Pay in Dividends
March 13, 2024
See how to construct a $1 million portfolio.
Via
The Motley Fool
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
With over 100 dividend growth stocks in its portfolio, the SCHD ETF has proved to be a formidable income-generating vehicle for investors.
Via
InvestorPlace
Topics
ETFs
Is AbbVie Stock a Buy Now?
February 29, 2024
Some would say the growth story is over, but that view might be a bit myopic.
Via
The Motley Fool
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
February 28, 2024
Via
Benzinga
3 Must-Have Dividend Kings for a Steady Income Stream
March 12, 2024
Discover the dividend kings with constant growth, dominating pharmaceuticals, household products and biotechnology industries.
Via
InvestorPlace
Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What
March 11, 2024
With economic conditions presenting a question mark for the consumer economy, these dividend stocks may shine brightly.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test
March 11, 2024
The company tested its psoriatic arthritis drug over 24 weeks against Humira.
Via
Investor's Business Daily
Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
March 11, 2024
Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, and 80% PASI90 by week 24. Unprecedented improvements compared to competitors.
Via
Benzinga
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
March 11, 2024
There are some great companies at attractive prices in the lucrative pharmaceutical space.
Via
The Motley Fool
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
March 09, 2024
Dive into the world of three unstoppable mega-cap stocks leading the charge amidst the bullishness in the market.
Via
InvestorPlace
The AI Race Gets Litigious
March 09, 2024
We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
March 09, 2024
These businesses can pack a punch in your portfolio over the long run.
Via
The Motley Fool
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
FDA grants accelerated approval to BeiGene's Brukinsa for relapsed/refractory follicular lymphoma. Approved in combination with Roche's Gazyva after two or more lines of therapy. Brukinsa, priced at...
Via
Benzinga
Exposures
Product Safety
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
March 06, 2024
These three dividend stocks have proved themselves to be among the best Dividend Aristocrats to buy for high-growth returns.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
The Top 7 Dividend Stocks to Buy in March 2024
March 06, 2024
Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance.
Via
InvestorPlace
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
March 04, 2024
Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends.
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 01, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Better Dividend Growth Stock: AbbVie or Amgen?
February 29, 2024
A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.
Via
The Motley Fool
3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade
February 27, 2024
These stocks don't offer the highest yields, but their payouts are growing fast.
Via
The Motley Fool
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
February 26, 2024
FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.
Via
Benzinga
3 Dividend Stocks That Are No-Brainer Buys Right Now
February 24, 2024
These stocks check off multiple boxes for investors.
Via
The Motley Fool
Is AbbVie Stock a Buy Now?
February 22, 2024
Management pivoting a $300 billion company as quickly as it has is nothing short of remarkable.
Via
The Motley Fool
5 Forever Dividend Stocks to Build Your Portfolio
February 20, 2024
These five stocks are high quality and reliable.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
February 19, 2024
These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.